Vetoquinol S.A (VETO) | Stock Overview & Key Data
Vetoquinol S.A. | Mid-cap | Healthcare
Vetoquinol S.A. | Mid-cap | Healthcare
Vetoquinol S.A Performance Comparison
Stock Range
Today's Range
Low: €76.10
High: €79.10
on September 23, 2025
52 Week Range
Low: €63.60
High: €87.70
on January 23, 2025
on October 9, 2024
All-Time High: €161.00 on November 1, 2021
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Market Cap
€951.7M
EPS
4.98
P/E Ratio (TTM)
16.08
Forward P/E
14.83
P/B Ratio
1.64
PEG Ratio
N/A
Div. Yield
1.27%
ROE
10.64%
Beta
0.745
Debt to Equity
3.67
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
16.28%
Profit Margin
10.88%
Returns and Earnings
Return on Assets (TTM)
6.66%
Return on Equity (TTM)
10.64%
EBITDA
€113.0M
Net Income (TTM)
€58.7M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€45.70
Quarterly Revenue Growth (YoY)
0.60%
Quarterly Earnings Growth (YoY)
49.50%
Dividend Information
Last 12-Month Dividend
€0.89
Current Dividend Yield
1.27%
3-Year Average Dividend Yield
0.99%
3-Year Average Annual Dividend
€0.85
3-Year Total Dividends
€2.54
Ex-Dividend Date
June 4, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Vetoquinol S.A VETO | 951.66M Mid-cap | -5.27% | 2.79% | 7.96% | -7.76% | 1.71% | -8.41% | -3.38% | 5.89% |
| Ipsen S.A IPN | 9.52B Large-cap | -1.95% | -0.69% | 14.98% | 6.23% | 2.48% | 3.95% | 22.13% | 36.03% |
| Boiron S.A BOI | 494.82M Mid-cap | 16.56% | 26.11% | 26.39% | 18.75% | 6.54% | -10.80% | -35.59% | -33.72% |
| Euroapi S.A.S.U EAPI | 290.40M Mid-cap | 3.64% | -5.15% | 4.68% | 13.82% | 5.39% | -21.75% | -81.63% | -76.83% |
| AB Science S.A AB | 84.59M Small-cap | 4.84% | 0.78% | -3.70% | -5.80% | 44.44% | 26.21% | -82.74% | -88.62% |
| CoreTech Limited MLCOT | 2.55M Small-cap | 0.00% | -41.67% | -46.15% | 180.00% | 1,300.00% | 600.00% | 250.00% | 250.00% |
Ownership & Short Interest
Insider Ownership
67.06%
Institutional Ownership
12.39%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
8K
Average 90-Day Volume
4K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is VETO's 52-week high and low?
- In the last 52 weeks, Vetoquinol S.A reached a high of €87.70 (on October 9, 2024) and a low of €63.60 (on January 23, 2025).
- What is the market cap and P/E ratio for VETO?
- Curious about Vetoquinol S.A's size and valuation? Its market capitalization stands at 951.66M. When it comes to valuation, the P/E ratio (trailing twelve months) is 16.08, and the forward P/E (looking ahead) is 14.83.
- Does VETO pay dividends? If so, what's the yield?
- Yes, Vetoquinol S.A is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.27%, and the company has paid an average of €0.85 per share annually over the past 3 years.
- Who are Vetoquinol S.A's main competitors or similar companies to consider before investing?
When looking at Vetoquinol S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Ipsen S.A
IPN9.52B Healthcare Drug Manufacturers - Specialty & Generic 3.95% 22.13% Boiron S.A
BOI494.82M Healthcare Drug Manufacturers - Specialty & Generic -10.80% -35.59% Euroapi S.A.S.U
EAPI290.40M Healthcare Drug Manufacturers - Specialty & Generic -21.75% -81.63% AB Science S.A
AB84.59M Healthcare Drug Manufacturers - Specialty & Generic 26.21% -82.74% CoreTech Limited
MLCOT2.55M Healthcare Drug Manufacturers - Specialty & Generic 600.00% 250.00% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Vetoquinol S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Vetoquinol S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 10.64%, the Debt to Equity ratio from the most recent quarter is 3.67, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for VETO?
- Looking at Vetoquinol S.A's growth, its revenue over the trailing twelve months (TTM) was €539M. Compared to the same quarter last year (YoY), quarterly revenue grew by 0.60%, and quarterly earnings saw a YoY growth of 49.50%.
- How much of VETO stock is held by insiders and institutions?
- Wondering who owns Vetoquinol S.A stock? Company insiders (like executives and directors) hold about 67.06% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 12.39%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.